4DS MEMORY LIMITED — Director's Dealing 2017

Nov 2, 2017

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity	4DS Memory Limited
ABN	43 145 590 110

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

irector for the purposes of section 205G of	the Corporations Act.
Name of Director	Mr David McAuliffe
Date of last notice	19 December 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest	Concept Biotech Pty Ltd (director related entity)
(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest.	David Jerimiah McAuliffe (trustee and beneficiary)
Date of change	3 November 2017
No. of securities held prior to	Direct
change	David McAuliffe
	700,000 fully paid Ordinary Shares
	997,588 fully paid Ordinary Shares escrowed until 17/12/2017
	Indirect
	Concept Biotech Pty Ltd
	2,498,812 fully paid Ordinary Shares escrowed until 17/12/2017
	David Jerimiah McAuliffe
	7,501,188 fully paid Ordinary Shares escrowed until 17/12/2017
Class	Fully paid ordinary shares
Number acquired	328,886 fully paid ordinary shares
Number disposed	-
Value/Consideration	$0.037 per share (deemed issue price)
includes brokerage/gst
Note: If consideration is non-cash, provide
details and estimated valuation

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held afterchange		DirectDavid McAuliffe1,028,886 fully paid Ordinary Shares997,588 fully paid Ordinary Shares escrowed until 17/12/2017IndirectConcept Biotech Pty Ltd2,498,812 fully paid Ordinary Shares escrowed until 17/12/2017David Jerimiah McAuliffe7,501,188 fully paid Ordinary Shares escrowed until 17/12/2017
Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities underdividend reinvestment plan, participation inbuy-back		Shares issued in lieu of salary payable to Mr McAuliffe asapproved by shareholders at the annual general meeting held on31 October 2017.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

sclosedinthis part.
Detail of contract	N/A-
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

**art 3– **+Closed period
Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearancewas required?	No
If so, was prior written clearance provided to allow the trade toproceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2